Zhu, S., Zhu, W., Zhao, K., Yu, J., Lu, W., Zhou, R., . . . Shan, P. (2024). Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy. BMC.
Citación estilo ChicagoZhu, Sujie, et al. Discovery of a Novel Hybrid Coumarin-hydroxamate Conjugate Targeting the HDAC1-Sp1-FOSL2 Signaling Axis for Breast Cancer Therapy. BMC, 2024.
Cita MLAZhu, Sujie, et al. Discovery of a Novel Hybrid Coumarin-hydroxamate Conjugate Targeting the HDAC1-Sp1-FOSL2 Signaling Axis for Breast Cancer Therapy. BMC, 2024.
Warning: These citations may not always be 100% accurate.